Literature DB >> 27407927

Management of Rh-isoimmunised Pregnancies : Our Experience.

D Arora1, T K Bhattacharyya2, S K Kathpalia3, Sps Kochar4, G S Sandhu5, B K Goyal6.   

Abstract

BACKGROUND: The aim of this study was to assess the role of middle cerebral artery peak systolic velocity (MCA-PSV), as measured by doppler ultrasound, in detecting foetal anaemia in Rh- isoimmunised pregnancies. Intra-uterine foetal blood transfusion was performed in such anaemic foetuses to tide over the crisis of foetal immaturity till considered fit for extra-uterine survival.
METHODS: Rh-isoimmunised pregnancies reporting to a tertiary institute from 2003 to 2005, were screened by doppler ultrasound to estimate MCA-PSV to detect foetal anaemia. If the foetus developed MCA-PSV of more than 1.5 multiple of median (MoM) for the gestational age, foetal blood sampling through cordocentesis was performed to confirm foetal anaemia, followed by intrauterine foetal blood transfusion to all anaemic foetuses at the same sitting. Neonatal outcome was evaluated by recording gestational age at the time of delivery, duration of gestational time gained and need for blood transfusion in the neonatal period.
RESULTS: A total of thirteen isoimmunised pregnancies were evaluated. Three pregnancies did not require in-utero foetal blood transfusion. Twenty-one intrauterine foetal blood transfusions were performed in the remaining ten patients. Five received blood transfusion in the neonatal period. Intra uterine foetal death occurred in one grossly hydropic foetus and favourable neonatal outcome was recorded in the rest.
CONCLUSION: The clinical outcome of these pregnancies justifies the use of doppler studies of MCA-PSV in detecting foetal anaemia and intra uterine foetal blood transfusion is the only hope of prolonging pregnancy and salvaging such foetuses.

Entities:  

Keywords:  Foetal anaemia; Foetal blood transfusion; Middle cerebral artery peak systolic velocity; Rh-isoimmunisation

Year:  2011        PMID: 27407927      PMCID: PMC4921685          DOI: 10.1016/S0377-1237(07)80096-7

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN: 0377-1237


  10 in total

1.  Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses.

Authors:  G Mari; R L Deter; R L Carpenter; F Rahman; R Zimmerman; K J Moise; K F Dorman; A Ludomirsky; R Gonzalez; R Gomez; U Oz; L Detti; J A Copel; R Bahado-Singh; S Berry; J Martinez-Poyer; S C Blackwell
Journal:  N Engl J Med       Date:  2000-01-06       Impact factor: 91.245

2.  Fetal blood sampling during pregnancy with use of a needle guided by ultrasound: a study of 606 consecutive cases.

Authors:  F Daffos; M Capella-Pavlovsky; F Forestier
Journal:  Am J Obstet Gynecol       Date:  1985-11-15       Impact factor: 8.661

3.  Rh disease: intravascular fetal blood transfusion by cordocentesis.

Authors:  K H Nicolaides; P W Soothill; C H Rodeck; W Clewell
Journal:  Fetal Ther       Date:  1986

4.  Normal values for human umbilical venous and amniotic fluid pressures and their alteration by fetal disease.

Authors:  C P Weiner; J Heilskov; G Pelzer; S Grant; K Wenstrom; R A Williamson
Journal:  Am J Obstet Gynecol       Date:  1989-09       Impact factor: 8.661

5.  Longitudinal assessment of the middle cerebral artery peak systolic velocity in healthy fetuses and in fetuses at risk for anemia.

Authors:  Laura Detti; Giancarlo Mari; Masashi Akiyama; Erich Cosmi; Kenneth J Moise; Theodor Stefor; Mark Conaway; Russell Deter
Journal:  Am J Obstet Gynecol       Date:  2002-10       Impact factor: 8.661

Review 6.  Noninvasive techniques to detect fetal anemia due to red blood cell alloimmunization: a systematic review.

Authors:  T G Divakaran; J Waugh; T J Clark; K S Khan; M J Whittle; M D Kilby
Journal:  Obstet Gynecol       Date:  2001-09       Impact factor: 7.661

7.  Sensorineural outcome at 2 years for survivors of erythroblastosis treated with fetal intravascular transfusions.

Authors:  L W Doyle; E A Kelly; A L Rickards; G W Ford; C Callanan
Journal:  Obstet Gynecol       Date:  1993-06       Impact factor: 7.661

8.  Management of fetal hemolytic disease by cordocentesis. II. Outcome of treatment.

Authors:  C P Weiner; R A Williamson; K D Wenstrom; S L Sipes; J A Widness; S S Grant; L Estle
Journal:  Am J Obstet Gynecol       Date:  1991-11       Impact factor: 8.661

9.  Erythroblastosis and reticulocytosis in anemic fetuses.

Authors:  K H Nicolaides; B Thilaganathan; C H Rodeck; R S Mibashan
Journal:  Am J Obstet Gynecol       Date:  1988-11       Impact factor: 8.661

10.  A retrospective review of isoimmunized pregnancies managed by middle cerebral artery peak systolic velocity.

Authors:  Lynn K McLean; Herman L Hedriana; Jan M Lanouette; Hanns C Haesslein
Journal:  Am J Obstet Gynecol       Date:  2004-06       Impact factor: 8.661

  10 in total
  2 in total

1.  A prospective cross-sectional study of fetal middle cerebral artery peak systolic velocity in a normal obstetric population attending an Indian Medical College.

Authors:  Sushil G Kachewar; Siddappa G Gandage; Hemant J Pawar
Journal:  Jpn J Radiol       Date:  2012-06-22       Impact factor: 2.374

2.  Fetal middle cerebral artery peak systolic velocities in a local Indian scenario.

Authors:  Sushil G Kachewar; Siddappa G Gandage; Devidas S Kulkarni
Journal:  Jpn J Radiol       Date:  2011-10-19       Impact factor: 2.374

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.